Document is current
Any future updates will be listed below
-
Authors
Zorrilla, I.
Lopez-Zurbano, S.
Alberich, S.
Barbero, I.
Lopez-Pena, P.
García-Corres, E.
Chart Pascual, J. P.
Crespo, J. M.
de Dios, C.
Balanzá-Martínez, V.
Gonzalez-Pinto, A.
-
Funding
Funding for this research was provided by:
Carlos III Health Research Institute (PI21/00713)
- License Information
-
More Information
Article History
Received: 23 December 2022
Accepted: 6 March 2023
First Online: 16 March 2023
Declarations
:
: This work was approved by the Ethical Committee of Hospital Universitario de Alava as stated in the methods section. Informed consent was obtained prior to inclusion in the study.
: Dr. Gonzalez-Pinto has received grants and served as consultant, advisor or CME speaker for the following entities: Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Sanofi-Aventis, Alter, Angelini, Exeltis, Novartis, Rovi, Takeda, the Spanish Ministry of Science and Innovation (CIBERSAM), the Ministry of Science (Carlos III Institute), the Basque Government, and the European Framework Program of Research. No other authors report conflict of interests.
